Apellis Pharmaceuticals Inc

NASDAQ:APLS 4:00:00 PM EDT

17.31

-0.12 (-0.69%)

: $17.30 -0.01 (-0.06%)

Market Cap (Intraday)	2.16B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$185.68 Million
Adjusted EPS	-$0.48

See more estimates

10-Day MA	$17.87
50-Day MA	$18.12
200-Day MA	$26.08

See more pivots

Apellis Pharmaceuticals Inc Stock, NASDAQ:APLS

100 5th Avenue, Suite A, Waltham, Massachusetts 02451-8703

United States of America

Phone: +1.617.977.5700

Number of Employees: 710

http://www.apellis.com

Description

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.